Grants per year
Personal profile
Certifications and Licenses
| Internal Medicine | |
| Hematology & Oncology |
Training Experience
| 2010 | Residency, University of Chicago |
| 2013 | Fellowship, Stanford University Hospitals |
Education/Academic qualification
MD, University of Chicago
… → 2007
Fingerprint Dive into the research topics where Shira Naomi Dinner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Medicine & Life Sciences
Multiple Myeloma
Medicine & Life Sciences
Immunoglobulin Light Chains
Medicine & Life Sciences
Amyloidosis
Medicine & Life Sciences
Hairy Cell Leukemia
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Medicine & Life Sciences
Leukocyte Count
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2014 2025
Alliance Operations - Administrative Core
Brigham and Women's Hospital, National Cancer Institute
4/4/19 → 2/28/25
Project: Research project
Budgets
Meals
Telecommunications
Triage
Lymphoma
CCITLA Supplement for The Robert H. Lurie Comprehensive Cancer Center
8/10/18 → 7/31/23
Project: Research project
Neoplasms
Medicine
Research
Population
Research Output 2008 2019
Moxetumomab pasudotox for hairy cell leukemia: Preclinical development to FDA approval
Lin, A. Y. & Dinner, S. N., Oct 8 2019, In : Blood Advances. 3, 19, p. 2905-2910 6 p.Research output: Contribution to journal › Article
Open Access
Drug Approval
Hairy Cell Leukemia
United States Food and Drug Administration
Immunotoxins
Capillary Leak Syndrome
Acute Lymphoblastic Leukemia in Adults
Dinner, S. N., Gurbuxani, S., Jain, N. & Stock, W., Jan 1 2018, Hematology: Basic Principles and Practice. Elsevier Inc, p. 1029-1054.e2Research output: Chapter in Book/Report/Conference proceeding › Chapter
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Citations
(Scopus)
Adolescent and young adult oncology, version 2.2018: Clinical practice guidelines in oncology
Coccia, P. F., Pappo, A. S., Beaupin, L., Borges, V. F., Borinstein, S. C., Chugh, R., Dinner, S., Folbrecht, J., Frazier, A. L., Goldsby, R., Gubin, A., Hayashi, R., Huang, M. S., Link, M. P., Livingston, J. A., Matloub, Y., Millard, F., Oeffinger, K. C., Puccetti, D., Reed, D. & 10 others, , Jan 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 1, p. 66-97 32 p.Research output: Contribution to journal › Review article
Practice Guidelines
Young Adult
Guidelines
Fertility
Counseling
Antibody-based therapies in patients with acute lymphoblastic leukemia
Dinner, S. N. & Liedtke, M., Nov 30 2018, In : Hematology. 2018, 1, p. 9-15 7 p.Research output: Contribution to journal › Article
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Antibodies
Residual Neoplasm
Therapeutics
Immunotherapy
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma
Dinner, S. N., Dunn, T. J., Price, E., Coutré, S. E., Gotlib, J., Berube, C., Kaufman, G. P., Medeiros, B. C. & Liedtke, M., Sep 1 2018, In : International journal of hematology. 108, 3, p. 267-273 7 p.Research output: Contribution to journal › Article
Multiple Myeloma
Dexamethasone
Maximum Tolerated Dose
Anthracyclines
Dizziness